Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

74.34 -2.68 (-3.48%)
Official Closing Price Updated: 4:00 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,039,694
Open 75.51
Bid (Size) 74.20 (1)
Ask (Size) 74.43 (2)
Prev. Close 77.02
Today's Range 74.14 - 75.78
52wk Range 57.00 - 148.15
Shares Outstanding N/A
Dividend Yield 2.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
Why Novo Nordisk Stock Sank by Nearly 4% Today
Via The Motley Fool

Performance

YTD
-15.1%
-15.1%
1 Month
+10.9%
+10.9%
3 Month
-7.2%
-7.2%
6 Month
-31.2%
-31.2%
1 Year
-47.0%
-47.0%

More News

Read More
Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard Saynor
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool
1 Growth Stock Down 9% to Buy Right Now
Via The Motley Fool
Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Why Novo Nordisk Stock Pumped Higher on Thursday
Via The Motley Fool
Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking
Via Stocktwits
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills
Via Benzinga
4 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility
Via The Motley Fool
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Should You Buy UnitedHealth Stock Instead of Novo Nordisk Stock?
Via The Motley Fool
McDonald's Just Got Hammered By Weight-Loss Drugs — Twice
Via Benzinga
Nvidia Extends AI Reach In Europe With Alliances
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels
Via Stocktwits
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies
Via Benzinga
Why Novo Nordisk Stock Just Popped
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Weight Loss Drug Stocks That Are Screaming Buys in June
Via The Motley Fool
Why Novo Nordisk Stock Eked Out a Win on Monday
Via The Motley Fool
Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch
Via Investor's Business Daily
Topics Bankruptcy
Exposures Financial Legal
Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy
Via Benzinga

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 74.34
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 06/17/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.